Free Trial
→ No. You’re not imagining it… (From Porter & Company) (Ad)tc pixel Free KNB Stock Alerts

Kanabo Group (KNB) Competitors

Kanabo Group logo
GBX 0.22 0.00 (0.00%)
As of 06/4/2026
Compare

KNB vs. TLY, SPI, MGP, SBI, and N4P

Should you buy Kanabo Group stock or one of its competitors? MarketBeat compares Kanabo Group with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Kanabo Group include Totally (TLY), Spire Healthcare Group (SPI), Medica Group (MGP), Sourcebio International (SBI), and N4 Pharma (N4P). These companies are all part of the "medical" sector.

How does Kanabo Group compare to Totally?

Totally (LON:TLY) and Kanabo Group (LON:KNB) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their risk, institutional ownership, valuation, profitability, media sentiment, analyst recommendations, earnings and dividends.

Totally has higher revenue and earnings than Kanabo Group. Kanabo Group is trading at a lower price-to-earnings ratio than Totally, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Totally£133.05M0.00-£3.79M-£1.93N/A
Kanabo Group£1.14M1.25-£8.18M-£1.42N/A

Totally has a net margin of -2.94% compared to Kanabo Group's net margin of -892.40%. Totally's return on equity of -8.85% beat Kanabo Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Totally-2.94% -8.85% -2.42%
Kanabo Group -892.40%-80.03%-20.89%

51.3% of Totally shares are owned by institutional investors. Comparatively, 3.8% of Kanabo Group shares are owned by institutional investors. 13.3% of Totally shares are owned by company insiders. Comparatively, 24.3% of Kanabo Group shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Totally has a beta of 0.55, indicating that its share price is 45% less volatile than the broader market. Comparatively, Kanabo Group has a beta of 3.04, indicating that its share price is 204% more volatile than the broader market.

In the previous week, Totally had 1 more articles in the media than Kanabo Group. MarketBeat recorded 1 mentions for Totally and 0 mentions for Kanabo Group. Totally's average media sentiment score of 0.00 equaled Kanabo Group'saverage media sentiment score.

Company Overall Sentiment
Totally Neutral
Kanabo Group Neutral

Summary

Totally beats Kanabo Group on 8 of the 12 factors compared between the two stocks.

How does Kanabo Group compare to Spire Healthcare Group?

Kanabo Group (LON:KNB) and Spire Healthcare Group (LON:SPI) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their risk, institutional ownership, earnings, media sentiment, dividends, valuation, analyst recommendations and profitability.

In the previous week, Spire Healthcare Group had 1 more articles in the media than Kanabo Group. MarketBeat recorded 1 mentions for Spire Healthcare Group and 0 mentions for Kanabo Group. Spire Healthcare Group's average media sentiment score of 0.75 beat Kanabo Group's score of 0.00 indicating that Spire Healthcare Group is being referred to more favorably in the news media.

Company Overall Sentiment
Kanabo Group Neutral
Spire Healthcare Group Positive

Kanabo Group has a beta of 3.04, indicating that its share price is 204% more volatile than the broader market. Comparatively, Spire Healthcare Group has a beta of 0.907, indicating that its share price is 9% less volatile than the broader market.

3.8% of Kanabo Group shares are held by institutional investors. Comparatively, 23.5% of Spire Healthcare Group shares are held by institutional investors. 24.3% of Kanabo Group shares are held by insiders. Comparatively, 39.3% of Spire Healthcare Group shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Spire Healthcare Group has a consensus target price of GBX 276, suggesting a potential upside of 26.46%. Given Spire Healthcare Group's stronger consensus rating and higher probable upside, analysts clearly believe Spire Healthcare Group is more favorable than Kanabo Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Kanabo Group
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Spire Healthcare Group
0 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
3.00

Spire Healthcare Group has higher revenue and earnings than Kanabo Group. Kanabo Group is trading at a lower price-to-earnings ratio than Spire Healthcare Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Kanabo Group£1.14M1.25-£8.18M-£1.42N/A
Spire Healthcare Group£1.58B0.55£28.15M£4.0054.56

Spire Healthcare Group has a net margin of 1.04% compared to Kanabo Group's net margin of -892.40%. Spire Healthcare Group's return on equity of 2.22% beat Kanabo Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Kanabo Group-892.40% -80.03% -20.89%
Spire Healthcare Group 1.04%2.22%3.73%

Summary

Spire Healthcare Group beats Kanabo Group on 14 of the 16 factors compared between the two stocks.

How does Kanabo Group compare to Medica Group?

Medica Group (LON:MGP) and Kanabo Group (LON:KNB) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, valuation, institutional ownership, risk, profitability, dividends, earnings and media sentiment.

Medica Group has a net margin of 9.35% compared to Kanabo Group's net margin of -892.40%. Medica Group's return on equity of 12.42% beat Kanabo Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Medica Group9.35% 12.42% 6.62%
Kanabo Group -892.40%-80.03%-20.89%

Medica Group has a beta of 1.1, suggesting that its share price is 10% more volatile than the broader market. Comparatively, Kanabo Group has a beta of 3.04, suggesting that its share price is 204% more volatile than the broader market.

Medica Group has higher revenue and earnings than Kanabo Group. Kanabo Group is trading at a lower price-to-earnings ratio than Medica Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Medica Group£76.98M0.00£7.20M£0.06N/A
Kanabo Group£1.14M1.25-£8.18M-£1.42N/A

In the previous week, Medica Group's average media sentiment score of 0.00 equaled Kanabo Group'saverage media sentiment score.

Company Overall Sentiment
Medica Group Neutral
Kanabo Group Neutral

88.4% of Medica Group shares are owned by institutional investors. Comparatively, 3.8% of Kanabo Group shares are owned by institutional investors. 2.9% of Medica Group shares are owned by company insiders. Comparatively, 24.3% of Kanabo Group shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Summary

Medica Group beats Kanabo Group on 8 of the 10 factors compared between the two stocks.

How does Kanabo Group compare to Sourcebio International?

Sourcebio International (LON:SBI) and Kanabo Group (LON:KNB) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, earnings, analyst recommendations, valuation, institutional ownership, dividends, risk and media sentiment.

Sourcebio International has a net margin of 0.00% compared to Kanabo Group's net margin of -892.40%. Sourcebio International's return on equity of 0.00% beat Kanabo Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Sourcebio InternationalN/A N/A N/A
Kanabo Group -892.40%-80.03%-20.89%

3.8% of Kanabo Group shares are held by institutional investors. 24.3% of Kanabo Group shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

In the previous week, Sourcebio International's average media sentiment score of 0.00 equaled Kanabo Group'saverage media sentiment score.

Company Overall Sentiment
Sourcebio International Neutral
Kanabo Group Neutral

Sourcebio International has higher revenue and earnings than Kanabo Group. Kanabo Group is trading at a lower price-to-earnings ratio than Sourcebio International, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Sourcebio International£75.61M0.00N/A£0.09N/A
Kanabo Group£1.14M1.25-£8.18M-£1.42N/A

Summary

Sourcebio International beats Kanabo Group on 6 of the 8 factors compared between the two stocks.

How does Kanabo Group compare to N4 Pharma?

N4 Pharma (LON:N4P) and Kanabo Group (LON:KNB) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their dividends, risk, analyst recommendations, media sentiment, profitability, institutional ownership, earnings and valuation.

N4 Pharma has a beta of -0.37, suggesting that its share price is 137% less volatile than the broader market. Comparatively, Kanabo Group has a beta of 3.04, suggesting that its share price is 204% more volatile than the broader market.

In the previous week, N4 Pharma's average media sentiment score of 0.00 equaled Kanabo Group'saverage media sentiment score.

Company Overall Sentiment
N4 Pharma Neutral
Kanabo Group Neutral

Kanabo Group has a net margin of -892.40% compared to N4 Pharma's net margin of -15,603.59%. Kanabo Group's return on equity of -80.03% beat N4 Pharma's return on equity.

Company Net Margins Return on Equity Return on Assets
N4 Pharma-15,603.59% -91.34% -56.00%
Kanabo Group -892.40%-80.03%-20.89%

0.2% of N4 Pharma shares are held by institutional investors. Comparatively, 3.8% of Kanabo Group shares are held by institutional investors. 22.0% of N4 Pharma shares are held by company insiders. Comparatively, 24.3% of Kanabo Group shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

N4 Pharma has higher earnings, but lower revenue than Kanabo Group. N4 Pharma is trading at a lower price-to-earnings ratio than Kanabo Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
N4 Pharma£7.07K800.95-£1.63M-£0.24N/A
Kanabo Group£1.14M1.25-£8.18M-£1.42N/A

Summary

Kanabo Group beats N4 Pharma on 8 of the 11 factors compared between the two stocks.

Get Kanabo Group News Delivered to You Automatically

Sign up to receive the latest news and ratings for KNB and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding KNB and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

KNB vs. The Competition

Export
MetricKanabo GroupMedical Care Facilities IndustryMedical SectorLON Exchange
Market Cap£1.42M£1.57B£6.49B£2.74B
Dividend YieldN/A3.78%2.67%6.16%
P/E Ratio-0.1612.6723.92366.44
Price / Sales1.2518.25507.5787,084.52
Price / Cash1.827.9026.9927.85
Price / Book0.241.7510.287.61
Net Income-£8.18M£63.03M£3.57B£5.89B
7 Day PerformanceN/A2.68%-1.43%-0.95%
1 Month PerformanceN/A3.64%3.27%1.56%
1 Year PerformanceN/A11.29%23.37%72.41%

Kanabo Group Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
KNB
Kanabo Group
N/AGBX 0.23
flat		N/AN/A£1.42M£1.14MN/A20
TLY
Totally
N/AGBX 0.25
+4.2%		N/A+0.0%£491K£133.05MN/A1,668
SPI
Spire Healthcare Group
2.5567 of 5 stars		GBX 217
-1.8%		GBX 276
+27.2%		+4.3%£869.30M£1.58B54.25420
MGP
Medica Group
N/AN/AN/AN/A£259.85M£76.98M3,516.671,212
SBI
Sourcebio International
N/AN/AN/AN/A£85.31M£75.61M1,277.78194

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (LON:KNB) was last updated on 6/8/2026 by MarketBeat.com Staff.
From Our Partners
Tiny Nasdaq Firm Lands €13.9 Million Semiconductor Deal
One small Nasdaq-listed company just landed a 13.9 million euro contract tied to a new advanced-node semicondu...
Finplays | Sponsoredtc pixel
Goldman Sachs just told you what to buy (most people missed it)
Goldman Sachs just revealed that 40% of AI data centers will be crippled by electricity shortages by 2027 - no...
Behind the Markets | Sponsoredtc pixel
No. You’re not imagining it…
Porter Stansberry, founder of one of the largest financial research firms in the world, says he's breaking the...
Porter & Company | Sponsoredtc pixel
One hidden supplier shipped 5 billion parts to SpaceX
Most investors are focused on the historic $1.75 trillion SpaceX IPO expected around June 30. But there's a le...
Weiss Ratings | Sponsoredtc pixel
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
Your book attached
Your Download Link (Expiring) If you still haven't downloaded the free Simple Options Trading For Beginners...
Profits Run | Sponsoredtc pixel
The REAL Reason Trump is Invading Iran
For a moment… Forget about Trump’s ties to Israel. Forget about reports of Iran’s nuclear program. Be...
Banyan Hill Publishing | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel